GMAB logo

Genmab A/S (GMAB) Cash from financing

annual CFF:

-$568.34M-$480.42M(-546.37%)
December 31, 2024

Summary

  • As of today (August 24, 2025), GMAB annual cash flow from financing activities is -$568.34 million, with the most recent change of -$480.42 million (-546.37%) on December 31, 2024.
  • During the last 3 years, GMAB annual CFF has fallen by -$501.59 million (-751.43%).
  • GMAB annual CFF is now -203.59% below its all-time high of $548.67 million, reached on December 31, 2019.

Performance

GMAB Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

quarterly CFF:

-$409.34M-$396.33M(-3046.58%)
June 1, 2025

Summary

  • As of today (August 24, 2025), GMAB quarterly cash flow from financing activities is -$409.34 million, with the most recent change of -$396.33 million (-3046.58%) on June 1, 2025.
  • Over the past year, GMAB quarterly CFF has increased by +$32.08 million (+7.27%).
  • GMAB quarterly CFF is now -174.44% below its all-time high of $549.88 million, reached on September 30, 2019.

Performance

GMAB quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

TTM CFF:

-$465.74M+$32.08M(+6.44%)
June 1, 2025

Summary

  • As of today (August 24, 2025), GMAB TTM cash flow from financing activities is -$465.74 million, with the most recent change of +$32.08 million (+6.44%) on June 1, 2025.
  • Over the past year, GMAB TTM CFF has increased by +$61.75 million (+11.71%).
  • GMAB TTM CFF is now -184.08% below its all-time high of $553.91 million, reached on September 30, 2019.

Performance

GMAB TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GMAB Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-546.4%+7.3%+11.7%
3 y3 years-751.4%-1208.7%-1300.2%
5 y5 years-203.6%-10000.0%-185.5%

GMAB Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-751.4%at low-2046.2%+7.3%-1300.2%+18.5%
5 y5-year-203.6%at low-2046.2%+7.3%-185.5%+18.5%
alltimeall time-203.6%at low-174.4%+7.3%-184.1%+18.5%

GMAB Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$409.34M(+3046.6%)
-$465.74M(-6.4%)
Mar 2025
-
-$13.01M(+658.5%)
-$497.83M(-12.9%)
Dec 2024
-$568.34M(+546.4%)
-$1.72M(-95.9%)
-$571.43M(-0.1%)
Sep 2024
-
-$41.68M(-90.6%)
-$571.76M(+8.4%)
Jun 2024
-
-$441.42M(+409.6%)
-$527.50M(+514.2%)
Mar 2024
-
-$86.61M(+4146.8%)
-$85.89M(-1.7%)
Dec 2023
-$87.93M(-21.1%)
-$2.04M(-179.1%)
-$87.35M(+35.9%)
Sep 2023
-
$2.58M(+1262.0%)
-$64.28M(-59.2%)
Jun 2023
-
$189.30K(-100.2%)
-$157.59M(-16.6%)
Mar 2023
-
-$88.08M(-518.8%)
-$189.06M(+70.9%)
Dec 2022
-$111.46M(+67.0%)
$21.03M(-123.2%)
-$110.63M(-13.8%)
Sep 2022
-
-$90.74M(+190.1%)
-$128.30M(+285.7%)
Jun 2022
-
-$31.28M(+224.2%)
-$33.26M(-18.6%)
Mar 2022
-
-$9.65M(-386.6%)
-$40.84M(-38.9%)
Dec 2021
-$66.75M(-714.8%)
$3.37M(-21.6%)
-$66.82M(+2.8%)
Sep 2021
-
$4.30M(-111.1%)
-$64.98M(-2.1%)
Jun 2021
-
-$38.86M(+9.1%)
-$66.37M(+146.4%)
Mar 2021
-
-$35.63M(-783.5%)
-$26.93M(-346.9%)
Dec 2020
$10.86M(-98.0%)
$5.21M(+79.5%)
$10.91M(-539.5%)
Sep 2020
-
$2.90M(+400.8%)
-$2.48M(-100.5%)
Jun 2020
-
$579.90K(-73.8%)
$544.50M(-0.6%)
Mar 2020
-
$2.21M(-127.0%)
$547.87M(+0.5%)
Dec 2019
$548.67M(-4989.1%)
-$8.18M(-101.5%)
$545.39M(-1.5%)
Sep 2019
-
$549.88M(>+9900.0%)
$553.91M(+8569.5%)
Jun 2019
-
$3.95M(-1564.7%)
$6.39M(-33.2%)
Mar 2019
-
-$269.90K(-178.7%)
$9.57M(-185.0%)
Dec 2018
-$11.22M(-134.4%)
$343.00K(-85.5%)
-$11.26M(+10.8%)
Sep 2018
-
$2.36M(-66.9%)
-$10.17M(+8.5%)
Jun 2018
-
$7.13M(-133.8%)
-$9.37M(+191.1%)
Mar 2018
-
-$21.10M(-1567.6%)
-$3.22M(-109.9%)
Dec 2017
$32.59M(+140.5%)
$1.44M(-54.4%)
$32.68M(-6.8%)
Sep 2017
-
$3.16M(-76.2%)
$35.06M(+19.2%)
Jun 2017
-
$13.29M(-10.3%)
$29.40M(+29.3%)
Mar 2017
-
$14.80M(+288.6%)
$22.74M(+67.1%)
Dec 2016
$13.55M(-85.8%)
$3.81M(-252.3%)
$13.61M(-20.4%)
Sep 2016
-
-$2.50M(-137.7%)
$17.11M(-54.7%)
Jun 2016
-
$6.63M(+16.9%)
$37.78M(-30.1%)
Mar 2016
-
$5.67M(-22.4%)
$54.01M(-43.9%)
Dec 2015
$95.61M(-48.1%)
$7.31M(-59.8%)
$96.19M(+9.3%)
Sep 2015
-
$18.17M(-20.5%)
$88.03M(+21.8%)
Jun 2015
-
$22.86M(-52.2%)
$72.29M(+44.1%)
Mar 2015
-
$47.85M(-5701.5%)
$50.18M(-72.9%)
Dec 2014
$184.23M(+582.4%)
-$854.30K(-135.1%)
$185.43M(-7.6%)
Sep 2014
-
$2.43M(+227.0%)
$200.58M(+0.3%)
Jun 2014
-
$744.30K(-99.6%)
$200.06M(-2.4%)
Mar 2014
-
$183.10M(+1180.4%)
$205.02M(+660.7%)
Dec 2013
$27.00M(-56.3%)
$14.30M(+649.8%)
$26.95M(-64.1%)
Sep 2013
-
$1.91M(-66.6%)
$75.13M(+2.9%)
Jun 2013
-
$5.71M(+13.5%)
$73.00M(+8.9%)
Mar 2013
-
$5.03M(-91.9%)
$67.01M(+8.6%)
Dec 2012
$61.74M
$62.48M(<-9900.0%)
$61.71M(-5976.4%)
Sep 2012
-
-$221.70K(-19.4%)
-$1.05M(-5.9%)
Jun 2012
-
-$275.20K(+0.3%)
-$1.12M(-1.6%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$274.50K(-1.5%)
-$1.13M(-1.0%)
Dec 2011
-$1.14M(-8.5%)
-$278.70K(-2.9%)
-$1.15M(-2.6%)
Sep 2011
-
-$287.00K(-2.3%)
-$1.18M(-1.0%)
Jun 2011
-
-$293.80K(+2.9%)
-$1.19M(+0.4%)
Mar 2011
-
-$285.50K(-7.7%)
-$1.18M(-4.9%)
Dec 2010
-$1.24M(-0.2%)
-$309.30K(+3.5%)
-$1.24M(-6.1%)
Sep 2010
-
-$298.70K(+3.5%)
-$1.32M(-6.2%)
Jun 2010
-
-$288.70K(-16.7%)
-$1.41M(-6.5%)
Mar 2010
-
-$346.50K(-11.3%)
-$1.51M(+21.2%)
Dec 2009
-$1.25M(-125.0%)
-$390.60K(+1.2%)
-$1.25M(-188.6%)
Sep 2009
-
-$386.10K(-0.1%)
$1.41M(-70.4%)
Jun 2009
-
-$386.60K(+372.0%)
$4.75M(-11.8%)
Mar 2009
-
-$81.90K(-103.6%)
$5.38M(+8.0%)
Dec 2008
$4.98M(-98.3%)
-
-
Dec 2008
-
$2.26M(-23.5%)
$4.98M(-39.1%)
Sep 2008
-
$2.96M(+1101.9%)
$8.19M(-7.7%)
Jun 2008
-
$245.90K(-151.4%)
$8.87M(-35.9%)
Mar 2008
-
-$478.40K(-108.8%)
$13.82M(-95.2%)
Dec 2007
$288.67M(+93.6%)
-
-
Dec 2007
-
$5.47M(+50.4%)
$288.67M(+0.9%)
Sep 2007
-
$3.63M(-30.2%)
$286.19M(+0.1%)
Jun 2007
-
$5.20M(-98.1%)
$286.01M(-0.6%)
Mar 2007
-
$274.37M(+9097.2%)
$287.77M(+93.0%)
Dec 2006
$149.11M(+201.5%)
-
-
Dec 2006
-
$2.98M(-13.6%)
$149.11M(+2.3%)
Sep 2006
-
$3.45M(-50.5%)
$145.74M(-21.5%)
Jun 2006
-
$6.97M(-94.9%)
$185.63M(+1.5%)
Mar 2006
-
$135.71M(<-9900.0%)
$182.92M(+269.9%)
Dec 2005
$49.46M(-41.4%)
-
-
Dec 2005
-
-$385.50K(-100.9%)
$49.46M(-1.6%)
Sep 2005
-
$43.34M(+918.5%)
$50.26M(-39.9%)
Jun 2005
-
$4.26M(+89.5%)
$83.67M(-0.9%)
Mar 2005
-
$2.25M(+436.2%)
$84.42M(-0.0%)
Dec 2004
$84.43M(<-9900.0%)
-
-
Dec 2004
-
$418.80K(-99.5%)
$84.43M(+0.8%)
Sep 2004
-
$76.75M(+1433.0%)
$83.72M(+1095.0%)
Jun 2004
-
$5.01M(+122.5%)
$7.01M(+283.8%)
Mar 2004
-
$2.25M(-871.5%)
$1.83M(-432.9%)
Dec 2003
-$548.40K(-102.7%)
-
-
Dec 2003
-
-$291.70K(-831.1%)
-$548.30K(+113.7%)
Sep 2003
-
$39.90K(-123.0%)
-$256.60K(-218.0%)
Jun 2003
-
-$173.20K(+40.5%)
$217.50K(-98.9%)
Mar 2003
-
-$123.30K(-124.0%)
$19.36M(-1.4%)
Dec 2002
$20.06M(>+9900.0%)
-
-
Sep 2002
-
$514.00K(-97.3%)
$19.64M(+2.7%)
Jun 2002
-
$18.97M(>+9900.0%)
$19.12M(>+9900.0%)
Mar 2002
-
$157.90K(<-9900.0%)
$166.00K(+2271.4%)
Dec 2001
$7000.00(-100.0%)
-$600.00(-90.0%)
$7000.00(-7.9%)
Sep 2001
-
-$6000.00(-140.8%)
$7600.00(-44.1%)
Jun 2001
-
$14.70K(-1436.4%)
$13.60K(-1336.4%)
Mar 2001
-
-$1100.00
-$1100.00
Dec 2000
$219.42M(+1454.5%)
-
-
Dec 1999
$14.11M
-
-

FAQ

  • What is Genmab A/S annual cash flow from financing activities?
  • What is the all time high annual CFF for Genmab A/S?
  • What is Genmab A/S annual CFF year-on-year change?
  • What is Genmab A/S quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Genmab A/S?
  • What is Genmab A/S quarterly CFF year-on-year change?
  • What is Genmab A/S TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Genmab A/S?
  • What is Genmab A/S TTM CFF year-on-year change?

What is Genmab A/S annual cash flow from financing activities?

The current annual CFF of GMAB is -$568.34M

What is the all time high annual CFF for Genmab A/S?

Genmab A/S all-time high annual cash flow from financing activities is $548.67M

What is Genmab A/S annual CFF year-on-year change?

Over the past year, GMAB annual cash flow from financing activities has changed by -$480.42M (-546.37%)

What is Genmab A/S quarterly cash flow from financing activities?

The current quarterly CFF of GMAB is -$409.34M

What is the all time high quarterly CFF for Genmab A/S?

Genmab A/S all-time high quarterly cash flow from financing activities is $549.88M

What is Genmab A/S quarterly CFF year-on-year change?

Over the past year, GMAB quarterly cash flow from financing activities has changed by +$32.08M (+7.27%)

What is Genmab A/S TTM cash flow from financing activities?

The current TTM CFF of GMAB is -$465.74M

What is the all time high TTM CFF for Genmab A/S?

Genmab A/S all-time high TTM cash flow from financing activities is $553.91M

What is Genmab A/S TTM CFF year-on-year change?

Over the past year, GMAB TTM cash flow from financing activities has changed by +$61.75M (+11.71%)
On this page